Sub-Total: $0.00
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Complimentary
Related products
-
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more -
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more -
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more
